Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: A pilot study

Thrombosis Research

Volumn 126, Issue 2, 2010, Pages

  Schroeder, Verena ^a   Ortner, Elisabeth ^a   Mono, Marie Luise ^b   Galimanis, Aekaterini ^b   Meier, Niklaus ^b   Findling, Oliver ^b   Fischer, Urs ^b   Brekenfeld, Caspar ^a   Arnold, Marcel ^b   Mattle, Heinrich P ^b   Kohler, Hans P ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b Neurologische Universitatsklinik Bern   (Switzerland)

^c Spital Netz Bern   (Switzerland)

Author keywords

Biomarker; Factor XIII; FXIII activation peptide; Ischaemic stroke

Indexed keywords

BLOOD CLOTTING FACTOR 13;

AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR SYMPTOM; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PILOT STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PILOT PROJECTS; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 77955714569     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.05.027     Document Type: Article

References (20)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
2. W. Hacke, M. Kaste, E. Bluhmki, M. Brozman, A. Dávalos, and D. Guidetti Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 2008 1317 1329
3. M. Di Napoli, and F. Papa Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients Stroke 33 2002 1763 1771
4. M. Woodward, G.D. Lowe, D.J. Campbell, S. Colman, A. Rumley, and J. Chalmers Associations of inflammatory and hemostatic variables with the risk of recurrent stroke Stroke 36 2005 2143 2147
5. E. Reganon, V. Vila, V. Martinez-Sales, A. Vaya, A. Lago, and P. Alonso Association between inflammation and hemostatic markers in atherothrombotic stroke Thromb Res 112 2003 217 221
6. L.S. Rallidis, M. Vikelis, D.B. Panagiotakos, G.K. Liakos, E. Krania, and D.T. Kremastinos Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients Acta Neurol Scand 117 2008 415 420
7. J. Isenegger, N. Meier, B. Lämmle, L. Alberio, U. Fischer, and K. Nedeltchev D-dimers predict stroke subtype when assessed early Cerebrovasc Dis 29 2010 82 86
8. Vanni S, Polidori G, Pepe G, Chiarlone M, Albani A, Pagnanelli A, Grifoni S. Use of biomarkers in triage of patients with suspected stroke. J Emerg Med. Prepublished on February 12, 2009, as DOI 10.1016/j.jemermed.2008.09.028.
9. J. Montaner, M. Perea-Gainza, P. Delgado, M. Ribo, P. Chacon, and A. Rosell Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers Stroke 39 2008 2280 2287
10. D.T. Laskowitz, S.E. Kasner, J. Saver, K.S. Remmel, and E.C. Jauch Clinical usefulness of a biomarker-based diagnostic test for acute stroke: The biomarker rapid assessment in ischemic injury (BRAIN) study Stroke 40 2009 77 85
11. L. Lorand Factor XIII: Structure, activation, and interactions with fibrinogen and fibrin Ann N Y Acad Sci 936 2001 291 311
12. V. Schroeder, J.M. Vuissoz, A. Caflisch, and H.P. Kohler Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form Thromb Haemost 97 2007 890 898
13. Ortner E, Schroeder V, Walser R, Zerbe O, Kohler HP. Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events. Blood 2010. Prepublished on April 7, 2010; DOI 10.1182/blood-2009-11-253062.
14. N. Alkjaersig, A.P. Fletcher, M. Lewis, and R. Ittyerah Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders Thromb Haemost 38 1977 863 873
15. N. Kucher, V. Schroeder, and H.P. Kohler Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness Thromb Haemost 90 2003 434 438
16. H.P. Kohler, R.A. Ariens, A.J. Catto, A.M. Carter, G.J. Miller, and J.A. Cooper Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men Br J Haematol 118 2002 825 832
17. R.A. Ariens, H.P. Kohler, M.W. Mansfield, and P.J. Grant Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension Arterioscler Thromb Vasc Biol 19 1999 2012 2016
18. T. Brott, H.P. Adams, C.P. Olinger, J.R. Marler, W.G. Barsan, and J. Biller Measurements of acute cerebral infarction: a clinical examination scale Stroke 20 1989 864 870 (Pubitemid 19188240)
19. H.P. Adams Jr, B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment Stroke 24 1993 35 41
20. S.E. Kasner Clinical interpretation and use of stroke scales Lancet Neurol 5 2006 603 612